PL2069395T3 - Nowe antygeny i przeciwciała związane z gruczolakorakiem przewodowym trzustki - Google Patents

Nowe antygeny i przeciwciała związane z gruczolakorakiem przewodowym trzustki

Info

Publication number
PL2069395T3
PL2069395T3 PL07820692T PL07820692T PL2069395T3 PL 2069395 T3 PL2069395 T3 PL 2069395T3 PL 07820692 T PL07820692 T PL 07820692T PL 07820692 T PL07820692 T PL 07820692T PL 2069395 T3 PL2069395 T3 PL 2069395T3
Authority
PL
Poland
Prior art keywords
antibodies
ductal adenocarcinoma
pda
pancreatic ductal
antibodies associated
Prior art date
Application number
PL07820692T
Other languages
English (en)
Polish (pl)
Inventor
Francesco Novelli
Barbara Tomaino
Paola Cappello
Original Assignee
Ribovax Biotechnologies Sa
Bioline Diagnostici Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ribovax Biotechnologies Sa, Bioline Diagnostici Srl filed Critical Ribovax Biotechnologies Sa
Publication of PL2069395T3 publication Critical patent/PL2069395T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57438—Specifically defined cancers of liver, pancreas or kidney
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88—Lyases (4.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y402/00—Carbon-oxygen lyases (4.2)
    • C12Y402/01—Hydro-lyases (4.2.1)
    • C12Y402/01011—Phosphopyruvate hydratase (4.2.1.11), i.e. enolase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/988—Lyases (4.), e.g. aldolases, heparinase, enolases, fumarase

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
PL07820692T 2006-09-29 2007-09-28 Nowe antygeny i przeciwciała związane z gruczolakorakiem przewodowym trzustki PL2069395T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP06121552 2006-09-29
EP06126726 2006-12-20
EP07820692A EP2069395B1 (en) 2006-09-29 2007-09-28 Novel antigens and antibodies associated to pancreatic ductal adenocarcinoma
PCT/EP2007/060305 WO2008037792A1 (en) 2006-09-29 2007-09-28 Novel antigens and antibodies associated to pancreatic ductal adenocarcinoma

Publications (1)

Publication Number Publication Date
PL2069395T3 true PL2069395T3 (pl) 2012-06-29

Family

ID=38895810

Family Applications (1)

Application Number Title Priority Date Filing Date
PL07820692T PL2069395T3 (pl) 2006-09-29 2007-09-28 Nowe antygeny i przeciwciała związane z gruczolakorakiem przewodowym trzustki

Country Status (18)

Country Link
US (1) US8071721B2 (cg-RX-API-DMAC7.html)
EP (1) EP2069395B1 (cg-RX-API-DMAC7.html)
JP (1) JP2010505104A (cg-RX-API-DMAC7.html)
KR (1) KR20090094227A (cg-RX-API-DMAC7.html)
CN (1) CN101578295B (cg-RX-API-DMAC7.html)
AT (1) ATE542831T1 (cg-RX-API-DMAC7.html)
AU (1) AU2007301966B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0717282A2 (cg-RX-API-DMAC7.html)
CA (1) CA2664841A1 (cg-RX-API-DMAC7.html)
DK (1) DK2069395T3 (cg-RX-API-DMAC7.html)
EA (1) EA016731B1 (cg-RX-API-DMAC7.html)
ES (1) ES2381304T3 (cg-RX-API-DMAC7.html)
IL (2) IL197868A (cg-RX-API-DMAC7.html)
NO (1) NO20091662L (cg-RX-API-DMAC7.html)
NZ (1) NZ576409A (cg-RX-API-DMAC7.html)
PL (1) PL2069395T3 (cg-RX-API-DMAC7.html)
PT (1) PT2069395E (cg-RX-API-DMAC7.html)
WO (1) WO2008037792A1 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012500964A (ja) * 2008-05-09 2012-01-12 デューク ユニバーシティ 癌の検出と治療における自己抗体
IT1398782B1 (it) 2009-09-11 2013-03-18 Novelli Peptide monofosforilato isolato derivato dall'alfa-enolasi umana utile per la diagnosi e il trattamento dell'adenocarcinoma pancreatico, anticorpi diretti contro il suddetto peptide monofosforilato e loro usi.
ITTO20120523A1 (it) * 2012-06-15 2013-12-16 Natimab Therapeutics S R L Procedimento e kit per la diagnosi in vitro dell'adenocarcinoma duttale pancreatico o per determinare la predisposizione all'adenocarcinoma duttale pancreatico
EP3083697B1 (en) * 2013-12-20 2019-04-17 Development Center for Biotechnology Alpha-enolase specific antibodies and methods of uses in cancer therapy
EP3094379A4 (en) 2014-01-13 2017-06-28 Berg LLC Enolase 1 (eno1) compositions and uses thereof
CN115786317A (zh) * 2022-12-12 2023-03-14 江苏三联生物工程股份有限公司 重组神经元特异性烯醇化酶及其制备方法与应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5753446A (en) * 1993-04-15 1998-05-19 National Jewish Center For Immunology & Respiratory Medicine Mitogen ERK kinase kinase (MEKK) assay

Also Published As

Publication number Publication date
WO2008037792A1 (en) 2008-04-03
CN101578295B (zh) 2013-02-27
NZ576409A (en) 2012-02-24
US20100028907A1 (en) 2010-02-04
IL218442A0 (en) 2012-04-30
IL197868A0 (en) 2011-08-01
EA016731B1 (ru) 2012-07-30
KR20090094227A (ko) 2009-09-04
ES2381304T3 (es) 2012-05-25
EA200970332A1 (ru) 2009-10-30
CN101578295A (zh) 2009-11-11
NO20091662L (no) 2009-06-29
EP2069395A1 (en) 2009-06-17
BRPI0717282A2 (pt) 2013-10-15
EP2069395B1 (en) 2012-01-25
CA2664841A1 (en) 2008-04-03
PT2069395E (pt) 2012-04-27
DK2069395T3 (da) 2012-05-14
IL197868A (en) 2013-03-24
JP2010505104A (ja) 2010-02-18
US8071721B2 (en) 2011-12-06
AU2007301966A1 (en) 2008-04-03
AU2007301966B2 (en) 2013-02-21
ATE542831T1 (de) 2012-02-15

Similar Documents

Publication Publication Date Title
MY162056A (en) Diagnosis and treatment of cancer using anti -ereg antibody
MX2009013824A (es) Proteinas de enlace de antigeno que enlazan par-2.
EP3885366A3 (en) Therapeutic antibodies against ror-1 protein and methods for use of same
MY150400A (en) Antibodies that bind human protein tyrosine phosphatase beta (hptpbeta) and uses thereof
IL218442A0 (en) Novel antigens and antibodies associated to pancreatic ductal adenocarcinoma
MX2008009886A (es) Anticuerpos que enlazan par-2.
MX2009006277A (es) Anticuerpos humanos que se enlazan a cd70 y usos de los mismos.
WO2009067660A3 (en) Anti-factor xi monoclonal antibodies and methods of use thereof
EP1996716A4 (en) MANIPULATED ANTI-PROSTATE STEAM CELL RESPONSIVES (PSCA) ANTIBODIES FOR CANCER TARGETING
MX2011010469A (es) Radicales de enlace al objetivo, armados con amatoxina para el tratamiento del cancer.
UA95068C2 (uk) Антиген-зв'язуюча молекула, яка зв'язує еgfr, вектор, що її кодує, та їх застосування
UA99602C2 (ru) Антитело, специфически связывающееся с jam-a, способное ингибировать пролиферацию опухолевых клеток
MX2010008570A (es) Anticuerpos alfa5-beta1 y sus usos.
BRPI0808940A8 (pt) anticorpo humano ou fragmento de ligação do mesmo, antígeno, polinucleotídeo, vetor, célula hospedeira, método para preparar um anticorpo ou um fragmento de ligação ou cadeia(s) de imunoglobulina do mesmo, anticorpo, cadeia de imunoglobulina ou um fragmento de ligação do mesmo, composição, usos do anticorpo ou fragmento de ligação, de um antígeno, de um polinucleotídeo, de um vetor, ou de uma célula, e de uma molécula de ligação a antígeno tumoral, método para clonagem molecular de um anticorpo, e, kit para o diagnóstico de um tumor
NO20084795L (no) Fremgangsmate for a behandle, diagnostisere eller detektere kreft
UA99601C2 (ru) Применение антитела к cd151 для лечения первичных опухолей
TW200635946A (en) Binding proteins specific for human matriptase
WO2022108976A3 (en) Anti-gpa33 multi-specific antibodies and uses thereof
WO2008109533A3 (en) Human antibodies that bind multiple irta family proteins, and uses thereof
MX2009008754A (es) Anticuerpos novedosos contra igf-1r.
WO2009087173A3 (en) Antibody designated barb3, barb3 related antibodies, and methods of making and using same
BR112012024997A2 (pt) peptídeos ect2 e vacinas incluindo os mesmos
BR112012022641A2 (pt) peptídeos hjurp e vacinas que incluem os mesmos
WO2022081443A3 (en) Anti-psma antibodies and uses thereof
MY192517A (en) Antibody specifically binding to pauf protein and use thereof